AAAAAA

   
Results: 1-25 | 26-29 |
Results: 26-29/29
Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome
Authors: Nakazawa, T Agematsu, K Yasui, K Onodera, T Inoue, R Kaneko, H Kondor, N Yamamoto, M Kayagaki, N Yagita, H Okumura, K Komiyama, A
Citation: T. Nakazawa et al., Cytolytic mechanisms involved in non-MHC-restricted cytotoxicity in Chediak-Higashi syndrome, CLIN EXP IM, 118(1), 1999, pp. 108-114
A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation
Authors: Hattori, K Hirano, T Miyajima, H Yamakawa, N Ikeda, S Yoshino, K Tateno, M Oshimi, K Kayagaki, N Yagita, H Okumura, K
Citation: K. Hattori et al., A metalloproteinase inhibitor prevents acute graft-versus-host disease while preserving the graft-versus-leukaemia effect of allogeneic bone marrow transplantation, BR J HAEM, 105(1), 1999, pp. 303-312
Fas/Fas ligand-mediated elimination of antigen-bearing Langerhans cells indraining lymph nodes
Authors: Kawamura, T Azuma, M Kayagaki, N Shimada, S Yagita, H Okumura, K
Citation: T. Kawamura et al., Fas/Fas ligand-mediated elimination of antigen-bearing Langerhans cells indraining lymph nodes, BR J DERM, 141(2), 1999, pp. 201-205
Serum soluble Fas/APO-1 is increased in patients with primary Sjogren's syndrome
Authors: Fujihara, T Takeuchi, T Tsubota, K Kayagaki, N Yagita, H Okumura, K Abe, T
Citation: T. Fujihara et al., Serum soluble Fas/APO-1 is increased in patients with primary Sjogren's syndrome, CLIN RHEUMA, 17(6), 1998, pp. 496-499
Risultati: 1-25 | 26-29 |